Engineered for versatility and antimicrobial protection

Now you can provide your patients antimicrobial protection around a wide variety of percutaneous devices.

Help to reduce risks across extraluminal access points

Use the Tegaderm CHG Chlorhexidine Gluconate gel pad 1664R pad for a variety of percutaneous devices, including implanted ports, large bore catheters, surgical drains and bone pins used in the care of oncology, haematology, orthopaedic and plastic surgery patients.

Tegaderm CHG is intended to reduce catheter-related bloodstream infections (CRBSI) in patients with central venous or arterial catheters. Tegaderm CHG Gel Pad 1664R provides site visibility and immediate and continuous antimicrobial protection against microorganisms associated with CRBSIs for up to 7 days withoutadditional moisture required to activate. The highly breathable film atop the CHG gel pad helps to release moisture. The gel pad remains clear and protects even in the presence of blood, saline and exudates. The adhesive border provides gentle, yet strong adherence to skin, and the pre-cut slit in the gel pad is designed to conform around a variety of percutaneous devices.

To use Tegaderm CHG Chlorhexidine Gluconate gel pad 1664R with intravascular devices, reference the below steps.

Prepare

Prepare site according to facility protocol. Ensure site is completely dry. Remove liner 1, then liner 2 as shown above.

Press

Place CHG gel pad around the device, covering the catheter insertion site and ensuring that the device rests upon the slit of the gel pad. Do not stretch during application. Apply firm pressure to enhance adhesion.

Secure

According to facility protocol, secure the catheter with the appropriate transparent, semi-permeable membrane dressing (e.g. Tegaderm HP, Tegaderm I.V. Port, Tegaderm I.V. Advanced Securement).

Monitor

Inspect the CHG gel pad daily and change as necessary, in accordance with facility protocol.

• Standalone CHG gel pad engineered for versatility and antimicrobial protection
• Tegaderm CHG is intended to reduce catheter-related bloodstream infections (CRBSIs) in patients with central venous or arterial catheters
• CHG gel pad provides immediate and continuous antimicrobial activity – reducing skin flora and preventing its re-growth – for up to 7 days
• Pre-cut slit conforms around drains, external fixator pins, implanted venous ports and a wide variety of other percutaneous devices (up to 40 FR)
• Transparent CHG gel pad allows continuous site visibility to easily assess for early signs of infection
• Adhesive border ensures gentle, yet strong adherence to skin
• Absorbs low amount of exudate* *Bench testing shows that CHG gel can absorb 8x its weight in saline and 3x its weight in blood